Extragonadal seminoma after renal transplantation and immunosuppression; treatment in the presence of renal dysfunctionA case report and literature review

被引:0
作者
Christos Kosmas
Nicolas B. Tsavaris
Maria Vadiaka
Theodoros Chiras
John Boletis
Alkis Kostakis
机构
[1] Laikon General Hospital,Medical Oncology Unit, Department of Pathophysiology Athens University School of Medicine
[2] Athens University School of Medicine,Transplantation Unit
[3] Laikon General Hospital,undefined
来源
Medical Oncology | 2001年 / 18卷
关键词
Immunosuppression; seminoma; renal transplantation; carboplatin; paclitaxel;
D O I
暂无
中图分类号
学科分类号
摘要
A 37-yr-old man who had undergone renal transplantation for end-stage renal failure presented with a large right pelvic mass obstructing the transplanted kidney. Initially, this was diagnosed as an anaplastic tumor while he had been on immunosuppressive treatment for kidney allograft rejection after transplantation. Despite difficulties of classic histopathology to reveal the origin of his tumor, FISH analysis revealed the presence of chromosome 12p abnormalities, strongly indicative of a germ-cell tumor—more likely seminoma—with extragonadal presentation. Because of renal dysfunction, he was treated with carboplatin (dose adjusted according to renal clearance) and etoposide, and when he experienced a rather atypical progression with bone metastases, he was treated with single-agent paclitaxel, and died almost 13 mo after initial presentation. The case adds further to the existing small list of seminoma/GCTs developing in transplant recipients, points to the unusual presentation patterns and diagnostic histopathology challenges, and presents the difficulty in therapeutic options, as a result of frequent renal dysfunction and intercurrent immunosuppressive therapy. All of these issues together with an extensive litterature review are discussed in detail.
引用
收藏
页码:221 / 225
页数:4
相关论文
共 94 条
[11]  
Penn I.(1989)Testicular seminoma in an immunosuppressed renal-transplant recipient Br. J. Urol. 63 549-550
[12]  
Hojo M.(1991)Cisplatin based chemotherapy in a renal-transplant recipient Cancer 68 1113-1117
[13]  
Morimoto T.(1992)A late manifestation of testicular seminoma in the bladder in a renal-transplant recipient—a case report J. Urol. 148 401-402
[14]  
Maluccio M.(2000)Metastatic extragonadal seminoma associated with cardiac transplantation Ann. Oncol. 11 749-752
[15]  
Asano T.(1993)Randomized trial of etoposide and cisplatin versus etoposide and carboplatin in patients with good-risk germ cell tumors: a multiinstitutional study J. Clin. Oncol. 11 598-606
[16]  
Morimoto K(1997)Randomized trial of bleomycin, etoposide, and cisplatin compared with bleomycin, etoposide, and carboplatin in good-prognosis metastatic nonseminomatous germ cell cancer: a Multiinstitutional Medical Research Council/European Organization for Research and Treatment of Cancer Trial J. Clin. Oncol. 15 1844-1852
[17]  
Lagman M.(2000)A medical research council randomized trial of single agent carboplatin versus etoposide and cisplatin for advanced metastatic seminoma Br. J. Cancer 83 1623-1629
[18]  
Hanto D.W.(1994)Phase II trial of paclitaxel shows antitumor activity in patients with previously treated germ cell tumors J. Clin. Oncol. 12 2277-2283
[19]  
Birkenbach M.(1995)Molecular and cytogenetic studies in the diagnosis of patients with poorly differentiated carcinomas of unknown primary site J. Clin. Oncol. 13 274-282
[20]  
Frizzera G.(1988)Blood group-related antigens in human germ cell tumors Cancer Res. 48 5342-5347